How everybody wins when playing by the rules: the benefits of investigator-initiated industry-sponsored clinical trials.

2007;28:262– 66 34. Kollia K, Maderwald S, Putzki N, et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009;30:699 –702 35. Gilbertson JR, Miller GM, Goldman MS, et al. Spinal dural arteriovenous fistulas: MR and myelographic findings. AJNR Am J Neuroradiol 1995;16:2049–57 36. Ferrer I, Kaste M, Kalimo H. Vascular diseases. In: Love S, Louis DN, Ellison DW, eds. Greenfield’s Neuropathology. Vol 1. London, UK: Hodder Arnold; 2008;121–240 37. Law M, Saindane AM, Ge Y, et al. Microvascular abnormality in relapsingremitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004;231:645–52 38. Inglese M, Park SJ, Johnson G, et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007;64:196 –202 39. Adhya S, Johnson G, Herbert J, et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006;33:1029 –35 40. Wakefield AJ, More LJ, Difford J, et al. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994;47:129 –33 41. Saindane AM, Law M, Ge Y, et al. Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis. AJNR Am J Neuroradiol 2007;28:767–72 42. Rosso C, Remy P, Creange A, et al. Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol 2006;27:1006 – 08 43. Rovira A, Pericot I, Alonso J, et al. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23:989 –94 44. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003;206:187–91 45. Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004;127:111–19 46. De Keyser J, Steen C, Mostert JP, et al. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab 2008;28:1645–51 47. Kalman B, Leist TP. A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med 2003;3:147–58 48. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175– 89 49. Lassmann H. Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci 2007;259:3– 6 M. Filippi M.A. Rocca Neuroimaging Research Unit Institute of Experimental Neurology Division of Neuroscience Scientific Institute and University Hospital San Raffaele Milan, Italy F. Barkhof Department of Radiology VU University Medical Centre Amsterdam, the Netherlands R. Bakshi Laboratory for Neuroimaging Research Partners Multiple Sclerosis Center Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston, Massachusetts F. Fazekas Department of Neurology Medical University of Graz Graz, Austria O. Khan Multiple Sclerosis Center Department of Neurology Wayne State University School of Medicine Detroit, Michigan D. Pelletier Departments of Neurology and Radiology University of California San Francisco, California A. Rovira Department of Radiology Hospital Vall d’Hebron Barcelona, Spain J. Simon Department of Radiology Oregon Health & Science University and the Portland Veterans Affairs Medical Center Portland, Oregon